Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MAZEN NOUREDDIN

Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology

NPI
1205087087
CMS profile
235390
Location
HOUSTON, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$166,496.48

103 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

103 matching records · $166,496.48 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 103 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 103.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
INTERCEPT PHARMACEUTICALS, INC. $23.3612/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261053825375 CMS
Merck Sharp & Dohme LLC $1,675.0012/18/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261048488187 CMS
ABBVIE INC. $15.3712/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026998023275 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $6,615.0012/07/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026997083155 CMS
Boehringer Ingelheim International GmbH $220.2512/05/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261017335009 CMS
Gilead Sciences, Inc. $9.7312/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261026073777 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $408.8012/04/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026996487569 CMS
Merck Sharp & Dohme LLC $670.0012/04/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261048435393 CMS
GlaxoSmithKline, LLC. $22.8011/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261001170161 CMS
GlaxoSmithKline, LLC. $81.1111/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261061461476 CMS
GlaxoSmithKline, LLC. $36.9111/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261061464350 CMS
Novo Nordisk AS $36.1911/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261006613713 CMS
Novo Nordisk AS $1,190.0011/13/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261006613753 CMS
Novo Nordisk Inc $427.8011/13/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261002482745 CMS
Novo Nordisk Inc $826.8211/13/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261002482833 CMS
Novo Nordisk Inc $7,586.2511/13/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261002658854 CMS
Novo Nordisk Inc $54.2211/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261002482653 CMS
Gilead Sciences, Inc. $131.8111/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261025504419 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $116.8411/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026996487581 CMS
Takeda Pharmaceuticals U.S.A., Inc. $67.1411/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261055515307 CMS
Novo Nordisk Inc $48.2910/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261002482641 CMS
Novo Nordisk Inc $391.6710/28/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261002482727 CMS
Novo Nordisk Inc $434.5710/28/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261002482757 CMS
Novo Nordisk Inc $910.3510/28/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261002482845 CMS
Novo Nordisk Inc $6,991.2510/28/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261002482857 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $20.3910/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261057342431 CMS
Novo Nordisk Inc $342.0010/06/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261002658723 CMS
Novo Nordisk Inc $2,394.0010/05/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261002658819 CMS
Siemens Medical Solutions USA, Inc. $1,150.0010/03/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026987540391 CMS
Novo Nordisk Inc $342.0010/02/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261002658711 CMS
Novo Nordisk Inc $2,394.0010/02/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261002658807 CMS
Gilead Sciences, Inc. $23.5209/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261025690459 CMS
Echosens North America, Inc. $82.3909/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261052146905 CMS
Sirtex Medical Inc $22.7509/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261032406665 CMS
Novo Nordisk Inc $42.0909/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261002482629 CMS
Novo Nordisk Inc $342.0008/30/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261002482705 CMS
Novo Nordisk Inc $684.0008/30/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261002482820 CMS
Novo Nordisk Inc $342.0008/30/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261002658699 CMS
Novo Nordisk Inc $684.0008/30/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261002658749 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $29.7608/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026996487573 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $74.4008/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026996487577 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $57.0408/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026997144583 CMS
PFIZER INC. $1,800.0008/04/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049930783 CMS
ABBVIE INC. $27.0908/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026998023273 CMS
Novo Nordisk Inc $595.0007/31/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261002658735 CMS
Novo Nordisk Inc $297.5007/28/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261002658687 CMS
Boehringer Ingelheim International GmbH $40.8207/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261017329547 CMS
INTERCEPT PHARMACEUTICALS, INC. $11.1507/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261053825371 CMS
GlaxoSmithKline, LLC. $9.1006/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261061461012 CMS
GlaxoSmithKline, LLC. $52.5906/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261061462666 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $71,908.51 66
PY2020 $66,405.46 26
PY2021 $30,851.78 13
PY2022 $99,517.08 66
PY2023 $166,496.48 103
PY2024 $258,389.60 151
PY2025 $782,701.65 137

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
MAZEN NOUREDDIN, NPI 1205087087. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1205087087.
APA 7
IndustryPayments. (2026). MAZEN NOUREDDIN, NPI 1205087087 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1205087087
Bluebook
MAZEN NOUREDDIN, NPI 1205087087, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1205087087.

Source: Centers for Medicare & Medicaid Services, Open Payments.